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The mosquito Aedes aegypti is the principal vector for arboviruses including dengue/yellow fever, chikungunya, 
and zika, infecting hundreds of millions of people annually. Unfortunately, traditional control methodologies are 
insufficient, so innovative control methods are needed. To complement existing measures, here we develop a 
molecular genetic control system termed precision guided sterile insect technique (pgSIT) in Aedes aegypti. 
PgSIT uses a simple CRISPR-based approach to generate sterile males that are deployable at any life stage. 
Supported by mathematical models,  we empirically demonstrate that released pgSIT males can compete, 
suppress, and eliminate mosquitoes in multigenerational population cages. This platform technology could be 
used in the field, and adapted to many vectors, for controlling wild populations to curtail disease in a safe, 
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Mosquitoes are the world's deadliest animals, killing more humans than any other animal (1) due to transmitting 
the majority of vector-borne diseases, such as the notorious arboviruses dengue, Zika, yellow fever, and 
chikungunya transmitted by Aedes mosquitoes. The predominating strategy to control these devastating diseases 
is the use of insecticides, though mosquitoes are evolving and spreading insecticide resistance (2), hampering 
control efforts. Therefore, there is an urgent demand for innovative mosquito-control technologies that are 
effective, sustainable, and safe.  
 
Alongside traditional control measures, several genetic-based techniques are being used to combat mosquitoes. 
These include multiple male (♂) release programs aimed at population suppression, such as the classical radiation-
based sterile insect technique (SIT), relying on releasing irradiated sterile ♂’s (3). Alternative approaches include 
the Wolbachia-based incompatible insect technique (IIT), relying on the release of Wolbachia infected ♂’s (4, 5), 
or the antibiotic-based Release of Insects carrying a Dominant Lethal (RIDL) (6). Moreover, emerging CRISPR-
based homing gene drives that spread target genes through a population faster than through traditional Mendelian 
inheritance are presently under development with the aim of safe implementation in the future (7, 8).  
 
As an alternative, a CRISPR-based technology termed precision-guided SIT (pgSIT), was recently developed in 
flies (9). pgSIT uses a binary approach to simultaneously disrupt genes essential for female (♀) viability and ♂ 
fertility, resulting in the exclusive survival of sterile ♂’s that can be deployed at any life stage to suppress 
populations. It requires two breeding strains, one expressing Cas9 and the other expressing guide RNAs (gRNAs). 
Mating between these strains results in RNA-guided mosaic target gene mutations throughout development, 
ensuring complete penetrance of desired phenotypes. Compared to alternatives, pgSIT does not require the use of 
radiation, Wolbachia, nor antibiotics, and will not persist in the environment. Unfortunately, this technology is 
presently only accessible in flies, and for population control techniques, its equivalent needs to be developed for 
mosquitoes.  
 
To address this, here we systematically engineer pgSIT in Ae. Aegypti using a system that simultaneously disrupts 
genes essential for ♂ fertility and ♀ flight, which is necessary for mating, blood feeding, reproduction, and 
predator avoidance—meaning survival in general (10). Using our technology, we demonstrate resulting progeny 
of flightless ♀’s and fit sterile ♂’s that can compete, suppress, and eliminate mosquito populations in 
multigenerational population cages. Mathematical models suggest that releases of Ae. aegypti pgSIT eggs could 
effectively eliminate a local Ae. aegypti population using achievable release schemes. Taken together, this study 
suggests pgSIT may be an efficient technology for mosquito population control and the first example of one suited 




Validation of  pgSIT target genes 
 
To engineer pgSIT in Ae. aegypti, we first validated target genes by generating transgenic gRNA-expressing lines 
targeting two conserved genes: β-Tubulin 85D (βTub, AAEL019894), specifically expressed in mosquito testes 
(11–13) and essential for spermatogenesis and ♂ fertility (14), and myosin heavy chain (myo-fem, AAEL005656), 
expressed nearly exclusively in ♀ pupae (11, 12) and essential for ♀ flight (15) (Fig. S1, Table S1). To ensure 
efficient disruption, each gRNA line encoded four U6–promoter-driven (16) gRNAs targeting unique sites in the 
coding sequence of either βTub (U6-gRNAβTub - marked with 3xP3-GFP) or myo-fem (U6-gRNAmyo-fem - marked 
with 3xP3-tdTomato) (Fig. S2-4). Multiple independent transgenic lines were generated, and to assess their 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.05.434167doi: bioRxiv preprint 
3 
activity, we conducted bidirectional crosses with Cas9 controlled by a homozygous nuclear pore complex protein 
(Cas9 - marked with Opie2-CFP) (17) (Table S2, S3, Fig. S2-4). The resulting transheterozygous F1 progeny 
(gRNA/+, Cas9/+) were assessed and crossed to wildtype (WT) for further evaluation. For the βTub crosses, 
fertility of the F1 transheterozygous ♂’s ranged from 0–94.9%, with two lines achieving 100% sterility from 
immotile sperm (14), while F1 transheterozygous ♀’s maintained normal fertility (Fig. 1, S2, Table S3, Video 
S1). For myo-fem crosses, all F1 transheterozygous ♀’s generated from ⅗ lines were flightless, while F1 
transheterozygous ♂’s maintained normal flight (Fig. 1, Table S3, Fig. S3, Video S2,3). As expected, ♀ 
flightlessness significantly reduced mating ability and blood consumption as many get trapped on the water 
surface following eclosion, resulting in reduced fecundity, fertility, and survival. Sanger sequencing of genomic 
DNA revealed expected mutations at the βTub- and myo-fem-targeted loci. 
 
Development of pgSIT and fitness assessments  
 
To generate a pgSIT strain capable of targeting both βTub and myo-fem simultaneously, we combined two gRNA 
lines that exclusively produced sterile ♂’s (gRNAβTub#7) or flightless ♀’s (gRNAmyo-fem#1) (Fig. 1, Fig. S2-S3, 
Table S3) by repeated introgression, generating a trans-homozygous stock (termed gRNAβTub+myo-fem) (Fig. S4). 
To assess its activity, we bidirectionally crossed gRNAβTub+myo-fem to Cas9. Importantly, these crosses yielded all 
flightless ♀’s (termed pgSIT♀) and sterile ♂’s (termed pgSIT♂) with normal flight and mating capacity (Fig. 2, 
S5, Table S4-8, Video S4-6). We next determined transgene integration sites,  single copy number per transgene, 
and confirmed target gene disruptions by both amplicon sequencing (Fig. S6) and Nanopore genome sequencing 
using transheterozygous pgSIT♂’s (Fig. S7-S9, Table S9-10). We also performed transcriptome sequencing of 
pupae comparing pgSIT♂’s and pgSIT♀’s to WT to quantify target gene reduction, expression from transgenes, 
and to assess global expression patterns (Fig. S8-S10, Table S11-S15). As expected, we observed significant 
target gene disruption in pgSIT individuals, robust expression from our transgenes, and non-target gene 
misexpression, which would be expected given the significant phenotypes observed (i.e. flightless females and 
spermless males).   
 
To explore potential fitness effects, we assayed several fitness parameters including ♀ fecundity, fertility, flight 
activity, ♂ mating capacity, ♂ sound attraction, larva-pupa development time, pupa-adult development time, and 
longevity (Fig. 2, S5, Table S5-8, Video S5-6). The pgSIT♀’s were flightless with significantly reduced fecundity, 
fertility, and survival, indicating they would be very unlikely to survive in the wild, let alone transmit pathogens. 
For pgSIT♂’s, other than slightly delayed larva-pupa development time, we did not detect significant differences 
in fitness parameters. Previous studies demonstrated that Ae. aegypti ♀’s typically mate only once in their lifetime, 
a behavior known as monandry (18). To explore whether prior matings with pgSIT♂’s could suppress ♀ fertility, 
we initiated experiments in which WT ♀’s were first mated with pgSIT♂’s for a period of time (2, 6, 12, 24, or 48 
hrs) followed by WT ♂’s (48 hrs). Fertility was measured for up to five gonotrophic cycles. We found that prior 
exposure to pgSIT♂’s ensured long lasting reductions in ♀ fertility, spanning 5 gonotrophic cycles, with longer 
exposures (24 and 48 hrs) resulting in near complete suppression of ♀ fertility  (Fig. 2, Table S8).  
 
pgSIT induced population suppression 
  
To assess whether pgSIT ♂’s could compete and suppress populations, we conducted discrete, multi-generational, 
population cage experiments by repeatedly releasing either eggs or adult ♂’s each generation, using several 
introduction frequencies (pgSIT:WT - 1:1, 5:1, 10:1, 20:1, and 40:1) (Fig. 3, Table S16). To measure efficacy 
each generation, we counted the total number of eggs laid and hatched and confirmed the lack of presence of 
marker genes in hatched larvae indicating released pgSIT ♂’s were indeed sterile. Adult releases at high release 
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thresholds (20:1, 40:1) eliminated all populations by generation 3, and at lower release thresholds (10:1), we saw 
elimination by generation 6. For the egg releases, elimination was achieved  by generation 6 for 4/6 populations 
at high release thresholds (20:1, 40:1). 
 
Theoretical performance of pgSIT in a wild population 
 
To explore the potential for pgSIT ♂’s to suppress Ae. aegypti populations in the wild, we simulated releases of 
pgSIT eggs on the island of Onetahi, Tetiaroa, French Polynesia (Fig. 4), a field site for releases of Wolbachia-
infected ♂ mosquitoes, using the MGDrivE simulation framework (19). Weekly releases of up to 400 pgSIT eggs 
per wild adult were simulated in each human structure over 10-24 weeks. The scale of these releases was chosen 
considering adult release ratios of 10:1 are common for sterile male mosquito interventions (6) and female Ae. 
aegypti produce >30 eggs per day in temperate climates (20). We also assumed 25% reductions in male mating 
competitiveness and adult lifespan for pgSIT males by default because, although pgSIT fitness effects were not 
apparent from laboratory experiments, they may become apparent in the field. Results from these simulations 
suggest that significant population suppression (>96%) is seen for a wide range of achievable release schemes, 
including 13 weekly releases of 120 or more pgSIT eggs per wild adult (Fig. 4, Video S7). Population elimination 
was common for larger yet achievable release schemes, including 18 weekly releases of 200 or more pgSIT eggs 
per wild adult, and 24 weekly releases of 100 or more pgSIT eggs per wild adult. Results also suggest a wider 
range of pgSIT fitness profiles (e.g. a 50% reduction in male mating competitiveness and 25% adult lifespan 




While many technologies for halting the spread of deadly mosquito-borne pathogens exist, none are without 
significant drawbacks such that additional measures are needed. By disrupting essential genes throughout 
development, we demonstrate efficient production of short-lived, flightless pgSIT♀’s and fit sterile pgSIT♂’s. 
Importantly, when repeatedly released into caged populations, the pgSIT♂’s competed with WT ♂’s thereby 
suppressing, and even eliminating, populations using release ratios that are achievable in the field (4–6). 
Mathematical models suggest that population elimination could be accomplished in the field through sustained 
releases of ~100-200 or more pgSIT eggs per wild Ae. aegypti adult, even if fitness costs significantly exceed 
those measured in contained laboratory experiments. 
 
For pgSIT to be realized in the wild, the two strains will first need to be separately and continuously mass-reared 
in a facility, without contamination, and crossed to produce sterile ♂’s. While this can be viewed as rate-limiting 
(21), it offers stability, as the binary CRISPR system will remain inactive until crossed—thereby reducing the 
evolution of suppressors or mutations that could disrupt the system. Additionally, each sorted ♀ can produce up 
to 450 eggs in her lifetime (22), which improves scalability. Moreover, once crossed, the resulting progeny are 
essentially dead-ends (i.e. sterile ♂’s /flightless ♀’s), hatched among high numbers of sterile pgSIT♂’s, and should 
not contribute to the gene pool (23). We demonstrate here that the technology is fully penetrant by screening 
>100K individuals. 
 
pgSIT offers an alternative approach to scalability that should help decrease costs and increase efficiency. For 
instance, the required genetic cross at scale can be initiated using existing robotic sex sorting devices 
(www.senecio-robotics.com) or (5). Upon sex sorting and crossing, the resulting pgSIT progeny can be distributed 
and released at any life stage, mitigating requirements for sex separation at field sites. This strategy will be 
especially effective for mosquitoes that diapause during the egg stage (e.g. Aedes species) because it will enable 
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long-term egg accumulation. Eggs could be distributed to logistically spaced remote field sites where they can 
hatch, develop, and compete with wild mosquitoes (Fig. S11). This attractive feature should reduce the costs of 
developing multiple production facilities requiring on-site sex separation for manual release of fragile adults.  
 
It should be noted that the releases of adult pgSIT♂’s unexpectedly resulted in faster population suppression as 
compared to egg releases in multigenerational population cage experiments. We believe this to result from the 
slightly reduced egg hatching rates of pgSIT♂’s and their delayed larva-pupa development time, which likely 
enabled the co-released WT ♂’s first access to WT ♀’s. While this could impact the discrete generation population 
cage experiments conducted here, it should not be problematic for suppressing continuous populations in the wild.  
 
Finally, notwithstanding its inherently safe nature, pgSIT requires genetic modification, and regulatory use 
authorizations will need to be granted prior to implementation. While this could be viewed as a limitation (21), 
we don’t expect obtaining such authorizations to be insurmountable. In fact, we envision pgSIT to be regulated 
in a similar manner to Oxitec’s RIDL technology, which has been successfully deployed in many locations and 
recently received experimental use authorizations in the USA.  
 
Overall, the inherent self-limiting nature of pgSIT, offers a controllable safe alternative to technologies that can 
persist and spread in the environment, such as gene drives (8). Going forward, pgSIT may provide an efficient, 
safe, scalable, and environmentally friendly alternative next-generation technology for wild population control of 




Mosquito rearing and maintenance 
 
Ae. aegypti mosquitoes were derived from the Liverpool strain (wildtype [WT]) previously used to generate the 
reference genome (24). Mosquitoes were raised in incubators at 27.0°C with 20–40% humidity and a 12-hour 
light/dark cycle in cages (Bugdorm, 24.5 cm 𝗑 24.5 cm 𝗑 24.5 cm). Adults were provided 0.3 M aqueous sucrose 
ad libitum, and ♀’s were blood fed on anesthetized mice for two consecutive days for ~15 minutes at a time. 
Oviposition substrates were provided ~3 days following the second blood meal. Eggs were collected and aged for 
~4 days to allow for embryonic development, then were hatched in deionized H2O in a vacuum chamber. Roughly 
~400 larvae were reared in plastic containers (Sterilite, 34.6 cm 𝗑 21 cm 𝗑 12.4 cm, USA) with ~3 liters of 
deionized H2O, and fed fish food (TetraMin Tropical Flakes, Tetra Werke, Melle, Germany). For genetic crosses, 
to ensure ♀ virginity, pupae were separated and sexed under the microscope by sex-specific morphological 
differences in the genital lobe shape (at the end of the pupal abdominal segments just below the paddles) before 
being released to eclose in cages. These general rearing procedures were followed unless otherwise noted. 
Mosquitoes were examined, scored, and imaged using the Leica M165FC fluorescent stereo microscope equipped 
with the Leica DMC2900 camera. For higher resolution images, we used a Leica DM4B upright microscope 
equipped with a VIEW4K camera enabling time lapse videos. Time lapse videos of caged adult mosquitoes were 
taken with a mounted Canon EOS 5D Mark IV using a 24–105mm image stabilizer ultrasonic lens.  
 
Guide RNA design and testing 
 
Two target genes were selected for gRNA design: β-Tubulin 85D (βTub, AAEL019894) and myosin heavy chain 
(myo-fem, AAEL005656). For each target gene, DNA sequences were first identified using reference genome 
assembly (24), and genomic target sites were validated using PCR amplification and Sanger sequencing (Table 
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S18 for primer sequences). Gene structures, transcripts, and exon-intron junction boundaries were carefully 
evaluated using comprehensive developmental transcriptome data (11, 24) loaded into an internal genome 
browser. Target gRNA sequences were selected to be 20 bp (N20) in length, excluding the PAM (NGG) (25). For 
in silico gRNA selection, we used either CHOPCHOP V3.0.0 (https://chopchop.cbu.uib.no) or CRISPOR 
(http://crispor.tefor.net) to minimize potential genomic off-target cleavage events. In total, we designed four 
gRNAs targeting βTub and four gRNAs targeting myo-fem (Table S18). To confirm gRNA activity in vivo, each 
gRNA was in vitro synthesized prior to construct design (Synthego, CA, USA). Then 100 ng/ul of gRNA was 
individually injected into fifty preblastoderm stage embryos (0.5–1 hr old) derived from Exu-Cas9 maternally 
depositing mothers, per previous embryo-injection protocols (16, 17). The surviving G0 progeny were pooled (2–
5 individuals per pool), and genomic DNA was extracted using the DNeasy blood and tissue kit (Qiagen, Cat 
No./ID: 69506) following the manufacturer's protocols. To molecularly characterize the induced mutations, target 
loci were PCR amplified from extracted genomic DNA, and the PCR products were gel purified (Zymo Research, 
Zymoclean Gel DNA Recovery Kit, Cat No./ID: D4007). The purified products were either sent directly for 
sequencing or subcloned (Invitrogen, TOPO-TA, Cat No./ID: LS450641), wherein single colonies were selected 
and cultured in Laurel Broth (LB) with ampicillin before plasmid extraction (Zymo Research, Zyppy plasmid 
miniprep kit, Cat No./ID: D4036) and Sanger sequencing. Mutated alleles were identified in silico by alignment 
with WT target sequences. All primers used for PCR and sequencing, including gRNA target sequences, are listed 
in Table S18.  
 
Construct molecular design and assembly 
 
The Gibson enzymatic assembly method was used to engineer all constructs in this study (26). To generate the 
Nup50-Cas9 construct marked with CFP, OA-874PA (Addgene #164846), we used our previous plasmid for Cas9 
expression (Addgene plasmid #100608) as the backbone (17). The fragments of T2A-eGFP-P10-3’UTR and 
OpIE2-dsRed-SV40 were removed by cutting with restriction enzyme FseI. Then, the P10-3’UTR fragment was 
amplified from Addgene plasmid #100608 with primers 874-P10 and 777B. Another fragment, OpIE2-CFP-
SV40, was synthesized using gBlocks® Gene Fragment service (Integrated DNA Technologies, Coralville, Iowa). 
Both fragments were provided for the Gibson assembly into the cut backbone. We designed two constructs, OA-
1067A1 (Addgene #164847) and OA-1067K (Addgene #164848), each carrying four different gRNAs targeting 
either β-Tubulin 85D (βTub, AAEL019894) or myosin heavy chain (myo-fem, AAEL005656) genes.  
 
To engineer these plasmids, four intermediate plasmids, OA-1055A (gRNAβTub1&2), OA-1055B (gRNAβTub3&4), 
OA-1055W (gRNAmyo-fem1&2), and OA-1055X (gRNAmyo-fem3&4), each harboring two gRNAs, were generated by 
cutting a backbone plasmid OA-984 (Addgene plasmid #120363), which contains piggyBac elements and the 
3xP3-tdTomato transformation marker, with the restriction enzymes AvrII and AscI. Two gBlocks® Gene 
Fragments were then cloned in, each containing two gRNAs: one driven by U6b (AAEL017774) and one by U6c 
(AAEL017763) promoters (17). To assemble the final plasmid OA-1067A1, an intermediate plasmid OA-1067A 
was generated by linearizing the plasmid OA-1055B with the restriction enzyme BglII and inserting in the 
fragment of U6b-gRNAβTub1-U6c-gRNAβTub2 amplified with primers 1167.C1 and 1067.C2 from plasmid OA-
1055A. Then, the fragment of 3xP3-tdTomato was removed from plasmid OA-1067A using the restriction 
enzymes AscI and NotI and replaced with the 3xP3-eGFP transformation marker amplified with primers 
1067A1.C1 and 1067A1.C2 from the plasmid OA-961B (Addgene plasmid #104967). To assemble the final 
plasmid OA-1067K, OA-1055W was linearized with the restriction enzyme FseI, and the insertion of U6b-
gRNAmyo-fem3-U6c-gRNAmyo-fem4 was amplified with primers 1167.C5 and 1067.C6 from the plasmid OA-1055X. 
During each cloning step, single colonies were selected and cultured in LB medium with ampicillin, and then the 
plasmids were extracted (Zymo Research, Zyppy plasmid miniprep kit, Cat No./ID: D4036) and Sanger 
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sequenced. Final plasmids were maxi-prepped using (Zymo Research, ZymoPURE II  Plasmid Maxiprep kit, Cat 
No./ID: D4202) and Sanger sequenced. All primers are listed in Table S18. Complete plasmid sequences and 
plasmid DNA are available at www.addgene.com.  
 
Generation of transgenic lines 
 
Transgenic lines were generated by microinjecting preblastoderm stage embryos (0.5–1 hr old) with a mixture of 
the piggybac plasmid (200 ng/ul) and a transposase helper plasmid (phsp-Pbac, (200 ng/ul). Embryonic collection 
and microinjections were performed following previously established procedures (17). After 4 days of 
development post-microinjection, G0 embryos were hatched in deionized H2O in a vacuum chamber. Surviving 
G0 pupae were separated and sexed and divided into separate ♀ or ♂  cages (~20 cages total). The pupae eclosed 
inside these cages along with added WT ♂  pupae (added into the ♀ cages) or WT ♀ pupae (added into the ♂ 
cages) at 5:1 ratios (WT:G0). Several days post-eclosion (~4–7), enabling sufficient time for development and 
mating, a blood meal was provided, and eggs were collected, aged, then hatched. The hatched larvae with positive 
fluorescent markers were individually isolated using a fluorescent stereo microscope (Leica M165FC). To isolate 
separate insertion events, selected transformants were individually crossed to WT (5:1 ratios of WT:G1), and 
separate lines were established (Table S2). These were subjected to many generations of backcrosses to WT to 
isolate single insertion events. Each of these individual gRNA lines (OA-1067A1: gRNAβTub and OA-1067K: 
gRNAmyo-fem) were maintained as mixtures of homozygotes and heterozygotes with periodic selective elimination 
of WTs. The Cas9 line (OA-874PA: Nup50-Cas9) was homozygosed by ~10 generations of single-pair sibling 
matings selecting individuals with the brightest expressing transformation markers. Homozygosity was confirmed 
genetically by repeated test crosses to WT. 
 
Genetic testing of established lines  
 
To assess the activity of the transgenic lines generated, we performed a series of genetic crosses by releasing 
sexed pupae into cages. We first crossed gRNA lines (gRNA ♂ 𝗑 WT ♀) to generate heterozygotes. We next 
reciprocally crossed heterozygous  gRNAβTub/+ (lines #1–10) and the heterozygous gRNAmyo-fem/+ (lines #1–5), 
with homozygous Cas9 (1 ♂ 𝗑 10 ♀). To measure the fecundity, the resulting transheterozygous F1 progeny 
(gRNAβTub/+; Cas9/+), or (gRNAmyo-fem/+; Cas9/+), were reciprocally crossed to WT’s (50 ♂ 𝗑 50 ♀), keeping 
track of the grandparents genotypes (Fig. S2, S3, Table S3).  Control crosses of:  WT ♂ 𝗑 WT ♀; WT ♂ 𝗑 Cas9 
♀; Cas9 ♂ 𝗑 WT ♀; gRNA/+ ♂ 𝗑 Cas9 ♀;  gRNA/+ ♀ 𝗑 Cas9 ♂; gRNA/+ ♀ 𝗑 WT ♂; and gRNA/+ ♂ 𝗑 WT ♀ 
were also set up for comparisons (50 ♂ 𝗑 50 ♀). Adults were allowed to mate in the cage for 4–5 days, then blood 
meals were provided, and eggs were collected and hatched. The percentage of egg hatching (i.e. fertility) was 
estimated by dividing the total number of eggs laid by the total number of hatched eggs. Larvae-to-adult survival 
rates were calculated by dividing the total number of adults that emerged by the total number of larvae. Pupae-
adult survival rates were calculated by dividing the number of dead pupae by the total number of pupae. Flight 
capacity for each sex was calculated by dividing the total number that were flightless (observed by eye) by the 
total of number of adult mosquitoes of that sex. Blood acquisition rates were calculated by dividing the number 
of blood-fed ♀’s by the total number of ♀’s. To investigate ♂ internal anatomical features, testes and ♂  accessory 
glands (n = 20) were dissected in 1% PBS buffer for imaging.  
 
Generation and characterization of gRNAβTub+myo-fem 
 
To generate gRNAβTub+myo-fem, we genetically crossed gRNAβTub#7 (marked with 3xp3-GFP) with gRNAmyo-fem#1 
(marked with 3xp3-tdTomato). Resulting F1 transheterozygotes gRNAβTub#7 /+ ; gRNAmyo-fem#1 /+ were subjected 
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to multiple generations of single-pair sibling matings, carefully selecting individuals with the brightest expressing 
transformation markers, to generate a transhomozygous stock  (termed: gRNAβTub+myo-fem). Zygosity was 
confirmed genetically by repeated test crosses to WT. To measure efficacy, we bidirectionally crossed 
gRNAβTub+myo-fem with  Cas9 (50 ♂ 𝗑 50 ♀), generating F1 transheterozygotes  gRNAβTub+myo-fem/+ ; Cas9/+. Control 
crosses were also setup for comparisons: gRNAβTub+myo-fem ♂ 𝗑 gRNAβTub+myo-fem ♀;  gRNAβTub+myo-fem ♂ 𝗑 WT ♀; 
gRNAβTub+myo-fem ♀ 𝗑 WT ♂; Cas9 ♂ 𝗑 Cas9 ♀; Cas9 ♂ 𝗑 WT ♀; and Cas9 ♀ 𝗑 WT ♂; (50 ♂ 𝗑 50 ♀). To determine 
the fecundity and fertility, resulting transheterozygous F1’s (~3 days old) were bidirectionally crossed to WT’s 
(50 ♂ 𝗑 50 ♀; 10 replicates each). These were allowed to mate for ~2 days and then blood fed. Afterwards, eggs 
were collected for up to five consecutive gonotrophic cycles and hatched.  
 
Determination of transgene integration sites and copy number  
 
To determine the transgene insertion site(s) and copy number(s), we performed Oxford Nanopore DNA 
sequencing. We extracted genomic DNA using the Blood & Cell Culture DNA Midi Kit (Qiagen, Cat# 13343) 
from twenty adult transheterozygous pgSIT♂’s (3 days old) harboring all three transgenes (Cas9/+ ; gRNAβTub#7 /+ 
; gRNAmyo-fem#1 /+), following the manufacturer’s protocol. The sequencing library was prepared using the Oxford 
Nanopore SQK-LSK109 genomic library kit and sequenced on a single MinION flowcell (R9.4.1) for 72 hrs to 
generate an N50 read length for the set of 4088 bp. Basecalling was performed using ONT Guppy basecalling 
software version 4.4.1, generating 2.94 million reads above quality threshold Q≧7, which corresponds to 8.68 Gb 
of sequence data. To determine transgene copy number(s), reads were mapped to the AaegL5.0 reference genome 
(24) supplemented with transgene sequences (OA-1067A1: gRNAβTub;  OA-1067K: gRNAmyo-fem; and OA-874PA: 
Nup50-Cas9) using minimap2 (27). In total, 2,862,171 out of 2,936,275 reads (97.48%) were successfully mapped 
with a global genome-wide depth of coverage of 5.495. We calculated the mean coverage depth for all contigs in 
the genome (2310) and the three plasmids (OA-1067A1: gRNAβTub;  OA-1067K: gRNAmyo-fem; and OA-874PA: 
Nup50-Cas9) as well as normalized coverage (Table S9-S10). Transgene coverage ranged from 5.1 to 7.6, and 
normalized coverage ranged from 0.93 to 1.38. As compared to the three chromosomes, the coverages are 
consistent with the transgenes present at a single copy (Fig. S7).  
 
To identify transgene insertion sites, we inspected reads that aligned to the transgenes in the Interactive Genomics 
Viewer (IGV) browser. The reads extending beyond the boundaries of the transgenes were then analyzed to 
determine mapping sites within the genome. For OA-874PA, one read spanned the whole transgene (~11.5 kb) 
and extended 4 and 3.5 kb on both sides. The extending portions mapped to both sides of the position on 
NC_035109.1:33,210,105 (chromosome 3), with the nearest gene being AAEL023567, which is ~5 kb away. For 
OA-1067K, one read covered ~7 kb of the transgene extending ~10 kb off the 3' end, 9 kb of which map to the 
NC_035108.1:287,686-296,810 region (chromosome 2). A few other shorter reads map to the same location. The 
site is located in the intron of AAEL005206, which is a capon-like protein, and based on the RNA-seq data, it's 
expression does not appear to be affected in pgSIT animals. For OA-1067A1, the nanopore sequencing was unable 
to resolve the insertion site, presumably due to its insertion in one of the remaining gaps in the genome. Finally, 
using nanopore data, we confirmed genomic deletions in both pgSIT target genes - see AEL019894 and 
AAEL005656 as expected (Fig. S8-S9). The nanopore sequencing data has been deposited to the NCBI sequence 
read archive (SRA) under BioProject ID is PRJNA699282 with accession number SRR13622000.  
 
Transcriptional profiling and expression analysis 
 
To quantify target gene reduction and expression from transgenes as well as to assess global expression patterns, 
we performed Illumina RNA sequencing. We extracted total RNA using miRNeasy Mini Kit (Qiagen, Cat# 
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217004) from ten sexed pupae: WT ♀, WT♂, transheterozygous pgSIT♂’s, and  pgSIT♀  harboring all three 
transgenes Cas9/+; gRNAβTub#7 /+; gRNAmyo-fem#1 /+ with each genotype in biological triplicate (12 samples total), 
following the manufacturer’s protocol. DNase treatment was conducted using DNase I, RNase-free 
(ThermoFisher Scientific, Cat# EN0521), following total RNA extraction. RNA integrity was assessed using the 
RNA 6000 Pico Kit for Bioanalyzer (Agilent Technologies #5067-1513), and mRNA was isolated from ~1 μg of 
total RNA using NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB #E7490). RNA-seq libraries were 
constructed using the NEBNext Ultra II RNA Library Prep Kit for Illumina (NEB #E7770) following the 
manufacturer’s protocols. Briefly, mRNA was fragmented to an average size of 200 nt by incubating at 94°C for 
15 min in the first strand buffer. cDNA was then synthesized using random primers and ProtoScript II Reverse 
Transcriptase followed by second strand synthesis using NEB Second Strand Synthesis Enzyme Mix. Resulting 
DNA fragments were end-repaired, dA tailed, and ligated to NEBNext hairpin adaptors (NEB #E7335). Following 
ligation, adaptors were converted to the “Y” shape by treating with USER enzyme, and DNA fragments were size 
selected using Agencourt AMPure XP beads (Beckman Coulter #A63880) to generate fragment sizes between 
250 and 350 bp. Adaptor-ligated DNA was PCR amplified followed by AMPure XP bead clean up. Libraries 
were quantified using a Qubit dsDNA HS Kit (ThermoFisher Scientific #Q32854), and the size distribution was 
confirmed using a High Sensitivity DNA Kit for Bioanalyzer (Agilent Technologies #5067- 4626). Libraries were 
sequenced on an Illumina HiSeq2500 in single read mode with the read length of 50 nt and sequencing depth of 
20 million reads per library. Base calls were performed with RTA 1.18.64 followed by conversion to FASTQ 
with bcl2fastq 1.8.4. The reads were mapped to the AaegL5.0 (GCF_002204515.2) genome supplemented with 
OA-874PA, OA-1067A1, and OA-1067K sequences using STAR. On average, ~97.5% of the reads were mapped 
(Table S11). Gene expression was then quantified using featureCounts against the annotation release 101 GTF 
downloaded from NCBI (GCF_002204515.2_AaegL5.0_genomic.gtf). TPM values were calculated from counts 
produced by featureCounts and combined (Table S12).  
 
PCA and hierarchical clustering of the data show that the samples generally behaved as expected in clustering by 
sex and genotype (Fig. S10). DESeq2 was then used to perform differential expression analyses between pgSIT 
vs WT samples within each sex (Fig. S10, Table S13, S14), and a two-factor design consistently showed what 
changed in response to the genotype in both sexes (Table S15).  In a comparison between pgSIT♀  and WT ♀, 
660 genes were upregulated in pgSIT♀ and 392 were downregulated at an adjusted p-value < 0.05. The target 
gene, AAEL005656, was significantly downregulated in pgSIT♀ (Fig. S10C). In a comparison between pgSIT♂’s 
andWT♂ (Table S13), 2067 genes were upregulated in pgSIT♂’s and 2722 were downregulated at an adjusted p-
value < 0.05. The target gene, AEL019894, was strongly downregulated in pgSIT♂ (Fig. S10D). It’s important to 
note here that the CRISPR/Cas9 pgSIT system disrupts the DNA (not the RNA) so transcription is expected to 
occur; however, the transcripts produced will encode mutations and should be degraded by nonsense -mediated 
mRNA decay (NMD) mechanisms. Indeed, these mutant RNA’s can be observed in the IGV (Fig. S8, S9). In the 
two-factor comparison, 1447 genes were upregulated in pgSIT and 2563 were downregulated at an adjusted p-
value < 0.05 (Fig. S10E). For each DESeq2 comparison, gene ontology enrichments were performed on 
significantly differentially expressed genes, and these are provided as tabs in the corresponding tables (Table 
S13-S15). All Illumina RNA sequencing data has been deposited to the NCBI sequence read archive (SRA) under 
BioProject ID is PRJNA699282 with accession numbers SRR13620773-SRR13620784.  
 
Amplicon Sequencing of Target Loci  
 
To sample a variety of molecular changes at the gRNA target sites (myo-fem and βTub), we used the Amplicon-
EZ service by Genewiz® and followed the Genewiz® guidelines for sample preparation. Genomic DNA from 50 
WT and 50 pgSIT sexed pupae (25♀ + 25♂) were extracted separately using DNeasy Blood and Tissue Kit 
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(Qiagen, Cat No./ID: 69506) following the manufacturer's protocols. Primers with Illumina adapters (Table S18) 
were used to PCR amplify the genomic DNA. PCR products were purified using the Zymoclean Gel DNA 
Recovery Kit (Zymo Research, Cat No./ID: D4007). Roughly 50,000 one-directional reads were generated by 
Genewiz® and uploaded to Galaxy.org for analysis. Quality control for the reads was performed using FASTQC. 
Sequence data were then paired and aligned against the myo-fem or βTub sequence using Map with BWA-MEM 
under “Simple Illumina mode”. Sequence variants were detected using FreeBayes, with parameter selection level 
set to “simple diploid calling.” The amplicon sequencing data has been provided as File S1.  
 
Prior mating with pgSIT♂’s suppress ♀ fertility  
 
To determine whether prior matings with pgSIT♂ could reduce ♀ fertility, we initiated 15 cages each consisting 
of 250 mature (4–5 days old) pgSIT♂ combined with 50 mature (4–5 days old) WT virgin ♀. We allowed the 
pgSIT♂’s to mate with these ♀’s for a limited period of time (including: 2, 6, 12, 24, and 48 hrs; 3 replicate cages 
each). Cages were shaken every 3 minutes for the first half hour to increase mating opportunities. Following these 
time periods, all ♀’s were removed and transferred to new cages along with 250 WT mature ♂’s, cages were 
again shaken every 3 minutes for the first half hour to increase mating opportunities and left to mate for an 
additional 2 days.  The ♀’s were then blood fed, and each blood fed ♀ was individually transferred to a single 
narrow Polystyrene vial (Genesee Scientific Cat# 32-116), and eggs were collected and hatched for fertility 
determination. Following this, non-fertile ♀’s were then placed back into cages along with the original WT ♂’s, 
plus an additional 50 mature WT ♂’s, for another chance to produce progeny. This was repeated for up to five 
gonotrophic cycles. As controls, cages with 250 WT ♂’s and 50 WT ♀’s, or 50 unmated blood fed WT ♀’s with 
no ♂’s added, or 50 unmated blood fed WT ♀’s with 250 WT ♂ adults were also set up (Table S8).  
 
Life table parameters 
 
Life table parameters were assessed by comparing WT, homozygous gRNAβTub+myo-fem, homozygous Cas9, and 
transheterozygous pgSIT (gRNAβTub+myo-fem/+; Cas9/+) generated with Cas9 inherited from either the mother 
(maternal Cas9) or father (paternal Cas9). Larva/pupae development times were recorded as the number of days 
from hatched larvae to pupae and then to adults. One hundred larvae from each line were placed in separate larval 
rearing containers (Sterilite, 34.6 cm 𝗑 21 cm 𝗑 12.4 cm, USA), each with 3 liters of deionized water, and fed 
once a day. Larvae were counted twice daily until pupation, and then the date of pupation and emergence were 
recorded. Larval to pupae development time was calculated for each sex. Pupae were transferred to plastic cups 
(Karat, C-KC9) with 100 ml of water, and survivors were recorded until adulthood. ANOVA and Tukey post-hoc 
tests were performed to compare differences in larval and pupal development among all groups.  
 
For measuring ♂ /♀ longevity, we tested the variation in ♂ and ♀ longevity among different lines using two 
methods: (i) released along with WT of the opposite sex or (ii) without WT of the opposite sex. (i) One hundred 
WT, homozygous gRNAβTub+myo-fem, homozygous Cas9 newly eclosed adult mosquitoes (fifty ♂’s and fifty ♀’s) 
were maintained in a cage; fifty newly-eclosed pgSIT ♂’s (maternal cas9) and fifty newly-eclosed pgSIT ♂’s 
(paternal cas9) were caged with fifty newly-eclosed WT ♀’s; and finally, fifty newly-eclosed pgSIT ♀’s (maternal 
cas9) and fifty newly-eclosed pgSIT ♀’s (paternal cas9) were caged with fifty newly-eclosed WT ♂’s. (ii) Fifty 
♂’s or ♀’s from each line were released into a cage separately without the opposite sex. Adults were provided 
with 10% sucrose and monitored daily for survival until all mosquitoes had died (3 replicates).  
 
For measuring ♀ fecundity and fertility, ♀’s (n = 50) and ♂’s (n = 50) three days post-emergence raised under 
the same standardized larval conditions were placed into a cage and allowed to mate for 2 days. ♀ mosquitoes 
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were blood fed until fully engorged and were individually transferred into plastic vials with oviposition substrate. 
Eggs were stored in the insectary for 4 days to allow full embryonic development and then were hatched in a 
vacuum chamber. Fecundity was calculated as the number of eggs laid per ♀, and fertility was calculated as the 
percentage of eggs hatched per ♀. An analysis of variance (ANOVA) and a Tukey post-hoc test were performed 
to compare differences in fecundity and fertility among all groups.  
 
♂ mating capacity (how many ♀’s can be mated by one mature ♂ ) was measured as follows. Fifteen mature WT 
♀’s were caged with 1 mature ♂ of each genotype for 24 hours (1♂:15♀ ratio).  After 24 hours, the single ♂ was 
removed from all cages. Two days after the single ♂ was removed, 75 WT ♂’s were added to each cage that 
previously had a pgSIT ♂ (5♂:1♀ ratio). Blood meals were provided, and each blood fed ♀ was individually 
transferred to a single vial for egg collection. The fecundity and fertility of each ♀ was determined. The mating 
capacity was calculated as the total number of ♀’s - total number of fertile ♀’s. The mating capacity of WT, 
homozygous gRNAβTub+myo-fem , and homozygous Cas9 ♂ was equal to the number of fertile ♀’s. All statistical 
analyses were performed using GraphPad Prism software (GraphPad Software, La Jolla, California, USA). P 
values > 0.05 were considered not significant. 
 
Flight activity quantification 
 
Mosquitoes were reared at 28°C, 80% relative humidity under a 12:12 hr light:dark regime, and measurements of 
flight activity were performed using a Drosophila Activity Monitoring (DAM) System (TriKinetics, LAM25) 
using large tubes designed for mosquitoes (TriKinetics, PGT 25 x 125 mm Pyrex Glass). Individual 4–7 day-old, 
non-blood fed virgin ♀ and non-mated ♂ mosquitoes were introduced into the monitoring tubes, which contained 
10% sucrose (Sigma, Cat. S0389) at both ends of the tube as the food source. The DAM System was positioned 
vertically during the assays. Flight activity was measured over a period of 24 hrs by automatically calculating the 
number of times that mosquitoes passed through the infrared beam in the center of the tubes. The walls of the 
monitoring tubes were coated with Sigmacote (Sigma, Cat. SL2) to inhibit mosquitoes from walking upward. For 
preparing the wingless mosquitoes, the animals were anesthetized on ice, and the wings were removed using 
Vannas Scissor (World Precision Instruments, Cat. 14003). The wingless mosquitoes were allowed to recover for 
12 hrs before recording. Mosquitoes were manually checked after flight activity recording to ensure survival. 
Data acquisition was performed using the DAMSystem (TriKinetics)  (Fig. 2D, Video S5, Table S6). 
 
Sound attraction assay 
 
The sound attraction assay was performed in a chamber with a temperature of 28°C and humidity of 80%. Seven-
day old ♂’s were sex separated after the pupae stage. The day before testing, 30–40 ♂’s were transferred by 
mouth aspiration to a 15-cm3 mesh cage with a 10% sucrose bottle. ♂ mosquitoes were allowed to recover in the 
cage under a 12 hr:12 hr light:dark regime for 24 hrs. For each trial, a 10-second 600 Hz sine tone was applied 
on one side of the cage as a mating behavior lure, mimicking ♀ flight tones. The number of mosquitoes landing 
on the mesh area around the speaker box（10 cm2）was quantified at 5-second intervals throughout the 
stimulus. The average percent of mosquitoes landing around the speaker area out of the total cage post-sound 
presentation was calculated (Fig. 2E, Video S6, Table S7). Heatmaps were generated using Noldus Ethovision 
XT.  
 
Multigenerational population cage trials 
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To perform multigenerational population cage trials, two strategies were employed: (i) release of eggs; (ii) release 
mature adults (Fig. 3, Table S16). Cage trials were carried out using discrete non-overlapping generations. For 
the first release of eggs strategy (i), WT eggs and pgSIT eggs were hatched together using the following ratios of 
1:1 (100:100), 1:5 (100:500), 1:10 (100:1000), 1:20 (100:2000), and 1:40 (100:4000), and three biological 
replicates for each ratio (15 cages total). All eggs were hatched simultaneously, then separated into multiple 
plastic containers (Sterilite, 34.6 cm 𝗑 21 cm 𝗑 12.4 cm, USA). Roughly 400 larvae were reared in each container 
using standard conditions with 3 liters of deionized water and were allowed to develop into pupae. Pupae were 
placed in plastic cups (Karat, C-KC9) with ~100 ml of water (~150 pupae per cup) and transferred to large cages 
(BugDorm, 60cm 𝗑 60cm 𝗑 60cm) to eclose. All adults were allowed to mate for ~5–7 days. ♀’s were blood fed, 
and the eggs were collected. Eggs were counted and stored for ~4 days to allow full embryonic development, then 
100 eggs were selected randomly and mixed with pgSIT eggs with ratios of 1:1 (100:100), 1:5 (100:500), 1:10 
(100:1000), 1:20 (100:2000), and 1:40 (100:4000) to seed for the following generation, and this procedure 
continued for all subsequent generations. The remaining eggs were hatched to measure hatching rates and to 
screen for the possible presence of transformation markers. The hatching rate was estimated by dividing the 
number of hatched eggs by the total number of eggs.  
 
For the release of mature adults strategy (ii), 3–4-days-old mature WT adult ♂’s were released along with mature 
(3–4 days old) pgSIT adult ♂’s at release ratios: 1:1 (50:50), 1:5 (50:250), 1:10 (50:500), 1:20 (50:1000), and 
1:40 (50:2000), with three biological replicates for each release ratio (15 cages total). One hour later, 50 mature 
(3–4 days old) WT adult ♀’s were released into each cage. All adults were allowed to mate for 2 days. ♀’s were 
then blood fed and eggs were collected. Eggs were counted and stored for four days to allow full embryonic 
development. Then, 100 eggs were randomly selected, hatched, and reared to the pupal stage, and the pupae were 
separated into ♂ and ♀ groups and transferred to separate cages. Three days post eclosion, 50 (1:1), 250 (1:5), 
500 (1:10), 1000 (1:20), and 2000 (1:40) age-matched pgSIT mature ♂ adults were caged with these mature ♂’s 
from 100 selected eggs. One hour later, mature ♀’s from 100 selected eggs were transferred into each cage. All 
adults were allowed to mate for 2 days. ♀’s were blood fed, and eggs were collected. Eggs were counted and 
stored for 4 days to allow full embryonic development. The remaining eggs were hatched to measure hatching 
rates and to screen for the possible presence of transformation markers. The hatching rate was estimated by 





To model the expected performance of pgSIT at suppressing and eliminating local Ae. aegypti populations, we 
used the MGDrivE simulation framework (19). This framework models the egg, larval, pupal, and adult mosquito 
life stages with overlapping generations, larval mortality increasing with larval density, and a mating structure in 
which females retain the genetic material of the adult ♂ with whom they mate for the duration of their adult 
lifespan. The inheritance pattern of the pgSIT system was modeled within the inheritance module of MGDrivE, 
along with impacts on adult lifespan, male mating competitiveness, and pupatory success. We distributed Ae. 
aegypti populations according to human structures sourced from OpenStreetMap on the basis that Ae. aegypti is 
anthropophilic. Each human structure was assumed to have an equilibrium population of 16 adult Ae. aegypti, 
producing an equilibrium island population of 992. We implemented the stochastic version of the MGDrivE 
framework to capture random effects at low population sizes and the potential for population elimination. Weekly 
releases of up to 400 pgSIT eggs were simulated in all human structures of Onetahi over a period of 10-24 weeks. 
200 repetitions were carried out for each parameter set, and mosquito genotype trajectories, along with the 
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proportion of simulations that led to local population elimination, were recorded. Complete model and 
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Figure 1. Validation of pgSIT target genes. Cas9/gRNA-mediated disruption of βTub or myo-fem results in (A-C) male (♂) sterility 
or (D-E) female (♀) flightlessness, respectively. Schematics of genetic crosses to assess the efficiency of (A) βTub or (D) myo-fem 
disruption in the F1 transheterozygous progeny. (B) Histogram indicating the percent of fertile progeny for each of the various progeny 
genotypes using gRNAβTub#7 line. (C) Imaging of seminal fluid from WT and gRNAβTub#7/+;Cas9/+ mosquitoes, showing the difference 
in spermatid elongation caused by the disruption of βTub (Video S1). (E) Histogram showing percent of fertile and flight-capable 
mosquitoes in each cross using gRNAmyo-fem#1 line. (Video S1-S3). (F) Imaging showing the specific wing posture phenotype induced 
by the myo-fem disruption in females, but not in males, in which the resting wings were uplifted. Data from both paternal Cas9 crosses 
(Cas9♂ 𝗑 gRNA♀) and maternal Cas9 crosses (Cas9♀ 𝗑 gRNA♂) are shown (Fig. S2, S3, Table S3). Bar plots show means ± one 
standard deviation (SD), biological replicates, and mean and SD values rounded to a whole number. Statistical significance was 
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Figure 2. Genetic characterization of pgSIT. (A) The pgSIT cross between transhomozygous gRNA ♂’s harboring both gRNAβTub#7 
and gRNAmyo-fem#1 (termed: gRNAβTub+myo-fem) and the homozygous Cas9. The pgSIT cross was initiated reciprocally to generate F1 
transheterozygous progeny carrying either maternal or paternal Cas9. (B) Histogram comparing the survival and fitness of 
transheterozygous and heterozygous Cas9 or gRNA progeny to those of WT (Table S4, Video S4).(C) Experimental set-up to determine 
whether prior matings with pgSIT♂’s suppresses WT ♀ fertility. WT ♀’s were cohabitated with pgSIT♂’s for 2, 6, 12, 24, or 48 hours 
then WT ♀’s were transferred to a new cage along with WT ♂’s and mated for an additional 2 days. The ♀’s were then blood fed and 
individually transferred to a vial. Eggs were collected and hatched for fertility determination. Following this, non-fertile ♀’s were then 
placed back into cages along WT ♂’s for another chance to produce progeny. This was repeated for up to five gonotrophic cycles, and 
the percentage of fertile ♀’s in each group of 50 ♀’s was plotted (Table S8). (D) Flight activity of individual mosquitoes including was 
assessed for 24 hours using a vertical Drosophila Activity Monitoring (DAM) System, which uses an infrared beam to record flight 
(Table S6, Video S5). (E) To quantify the attractiveness of ♂’s to ♀’s for mating, we used a mating-behavior lure of a tone mimicking 
♀ flight. A 10-second 600 Hz sine tone was applied on one side of the cage, and a number of mosquito ♂’s landing on the mesh around 
a speaker was scored. Heatmaps were generated using Noldus Ethovision XT. (Table S7, Video S6). Plots show biological replicates 
and means ± SDs. Statistical significance was estimated using a two-sided Student’s t test with unequal variance. (p ≥ 0.05ns,  p < 
0.05*, p < 0.01**, and p < 0.001***).  
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Figure 3. Multigenerational cage trials demonstrating efficient population suppression. (A) To generate sufficient mosquitoes, 
three lines were raised separately, including homozygous Cas9, transhomozygous gRNAβTub+myo-fem, and WT. To generate pgSIT progeny, 
virgin Cas9 ♀’s were genetically crossed to gRNAβTub+myo-fem ♂’s, and eggs were collected. (B) To perform multigenerational population 
cage trials of pgSIT, two strategies were employed: release of eggs (B, top panel); release mature adults (B, bottom panel).  For both 
strategies, multiple pgSIT:WT release ratios were tested, including: 1:1, 5:1, 10:1, 20:1, and 40:1. Each generation, total eggs were 
counted, and 100 eggs were selected randomly to seed the subsequent generation. The remaining eggs were hatched to measure hatching 
rates and score transgene markers. This procedure was repeated after each generation until each population was eliminated (Table S7). 
(C) Multigeneration population cage data for each release threshold plotting the proportion of eggs hatched each generation.  
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Figure 4. Model-predicted impact of releases of pgSIT eggs on Ae. aegypti population density and elimination. (A) Releases were 
simulated on the island of Onetahi, Tetiaroa, French Polynesia, a field site for releases of Wolbachia-infected ♂ mosquitoes, using the 
MGDrivE simulation framework (19) and parameters described in Table S17. Human structures are depicted and were modeled as 
having an equilibrium population of 16 adult Ae. aegypti each. (B) Weekly releases of up to 400 pgSIT eggs per wild Ae. aegypti were 
simulated in each human structure over 10-24 weeks. The pgSIT construct was conservatively assumed to decrease male mating 
competitiveness by 25% and adult lifespan by 25%. Elimination probability was calculated as the percentage of 200 stochastic 
simulations that resulted in local Ae. aegypti elimination for each parameter set. Sample time-series depicting female Ae. aegypti 
population density are depicted above and below the heatmap. (C) Elimination probability (given 18 weekly releases of 200 pgSIT eggs 
per wild Ae. aegypti) is depicted for a range of pgSIT ♂ fitness profiles. Elimination is possible for a wide range of reductions in male 
mating competitiveness (0-50%) and adult lifespan (0-50%) for an achievable release scheme. 
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Figure S1. Conservation of target genes in Diptera. (A) Phylogenetic tree of Dipteran insects, including Drosophila melanogaster 
(D. melanogaster and D. mel.), Anopheles gambiae (An. gambiae and An. gam.), Culex quinquefasciatus (Cu. quinquefasciatus and Cu. 
quin.), Aedes aegypti (Ae. aegypti and Ae. aeg), and Aedes albopictus (Ae. albopictus and Ae. albo), with evolutionary distance measured 
by million years ago (MYA). All images are free to use and were downloaded from wiki commons, except Cu. quin., which was 
downloaded from Pixnio.com. (B) βTub orthologs in Dipteran species with highest similarity to the Ae. aegypti βTub gene at the amino 
acid level. (B’) RNA expression levels of the βTub gene throughout development. Extremely high expression of βTub is seen in Ae. 
albopictus testes samples (refer to Table S1 for TPM data of βTub expression across development). Lower gene expression is observed 
in both ♂ carcass and ♂ pupae samples. (C) myo-fem orthologs in Dipteran species with the highest similarity to the Ae. aegypti myo-
fem gene at the amino acid level. (C’) RNA expression levels of the myosin gene across development in both Ae. aegypti and Ae. 
albopictus mosquito samples. The myo-fem gene is highly expressed in the pupal samples of both mosquito species (refer to Table S1 
for TPM data of myo-fem expression across development). (B’ and C’) RNA-Seq expression levels of myo-fem and βTub genes in Ae. 
aegypti and Ae. albopictus mosquito samples using available data (11, 12). Major stages of development are color coded, where brown 
represents ♂ testes and ♂ carcass samples, pink represents ♀ carcass samples, red represents ovary samples, green represents 
embryogenesis, blue represents larval samples, and orange represents pupae samples. Black dotted lines represent Ae. aegypti, and solid 
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blue lines represent Ae. albopictus. The major developmental groups are indicated by color bars and are organized left to right, as 
follows: M (brown, ♂ testes, ♂ carcass), Fc (purple, NBF ♀ Carcass, and multiple time points PBM: 12, 24, 36, 48, 60, and 72 hr), Ov 
(red, NBF ovaries, and multiple ovarian time points PBM: 12, 24, 36, 48, 60, and 72 hr), Emb (green, embryo, 0–2, 2–4, 4–8, 8–12, 12–
16, 16–20, 20–24, 24–28, 28–32, 32–36, 36–40, 40–44, 44–48, 48–52, 52–56, 56–60, 60–64, 64–68, 68–72, and 72–76 hr embryos), L 




Figure S2. Assessment of independent gRNAβTub lines. (A) Schematic of the Ae. aegypti β-Tubulin (βTub) locus and the gRNAβTub 
construct used to generate 10 transgenic gRNAβTub lines. The gRNAβTub construct harbors four independent gRNAs targeting different 
sequences in the 1st coding exon of βTub (red lines) and a 3xP3-GFP marker gene. (B) A schematic of the genetic cross between the 
homozygous Cas9 ♀’s and heterozygous gRNAβTub/+ ♂’s generating the transheterozygous progeny inheriting maternal Cas9. To assess 
the efficiency of βTub disruption in F1 transheterozygous progeny, this cross was set up reciprocally between the homozygous Cas9 line 
and each of ten different insertion lines of gRNAβTub. The generated F1 transheterozygous ♂’s and ♀’s were crossed to WT mosquitoes 
of the opposite sex, and their fertility and fecundity, as an average number of laid eggs, were compared to those of F0 parents, 
homozygous Cas9, and WT mosquitoes. (C) The bar plots show biological replicates and means ± SDs for fertility and fecundity 
(Log10[laid eggs]) of tested groups (Table S3). Different insertion lines of the same gRNAβTub construct in conjunction with Cas9 induced 
a range of infertility in transheterozygous ♂’s from 90.6 ± 3.4% to 0%. Two lines, gRNAβTub#3 and gRNAβTub#7, independently induced 
the robust sterility of transheterozygous ♂’s where they harbored maternal or paternal Cas9: gRNAβTub♂/+; Cas9♀/+ or gRNAβTub♀/+; 
Cas9♂/+, respectively. The gRNAβTub#7 was the easiest to score due to its brighter expression of the 3xP3-GFP marker. Therefore, it 
was used for further analysis and genetically combined with the best gRNAmyo-fem line. Statistical significance was estimated using a two-
sided Student’s t test with unequal variance. (p ≥ 0.05ns,  p < 0.05*, p < 0.01**, and p < 0.001***).   
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Figure S3. Assessment of independent gRNAmyo-fem lines. (A) Schematic of the Ae. aegypti Myosin Heavy chain (Mhc, myo-fem) locus 
and the gRNAmyo-fem genetic construct used to generate five transgenic gRNAmyo-fem lines. The gRNAmyo-fem construct harbors four 
independent gRNAs targeting different sequences in the 1st exon of myo-fem (red lines) and a 3xP3-tdTomato marker gene. (B) A 
schematic of the genetic cross between the homozygous Cas9 ♀’s and heterozygous gRNAmyo-fem/+ ♂’s generating the transheterozygous 
progeny inheriting maternal Cas9. To assess the efficiency of myo-fem disruption in F1 transheterozygous progeny, this cross was set up 
in both reciprocal directions between the homozygous Cas9 line and each of five different insertion lines of gRNAmyo-fem. We scored the 
flight ability, pupal lethality, blood feeding, and fertility in generated F1 transheterozygous ♂’s and ♀’s and compared to WT and Cas9 
mosquitoes. (C) The bar plots show biological replicates and means ± SDs for assessed characteristics (Table S3). In the presence of 
Cas9, three out of five gRNAβTub lines induced the myo-fem disruption that resulted in the complete ♀-specific flightlessness, while 
transheterozygous ♂’s were able to fly. The ♀ inability to fly affected their blood feeding, mating, and survival, rendering 
transheterozygous ♀’s infertile. The gRNAmyo-fem#1 was the easiest to score due to its brighter expression of the 3xP3-tdTomato marker. 
Therefore, it was used for further analysis and genetically combined with the gRNAβTub#7 line. Statistical significance was estimated 
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Figure S4. Transmitted light and fluorescent images of mosquito life stages of strains used in this study. For each strain, multiple 
life stages are shown, including larvae (instar 4), pupae, and adult ♂’s and ♀’s. All stages are imaged using transmitted white light, GFP 
filter (Leica Part #10447408; ET470/40x, ET525/50m wavelengths), RFP filter (Leica Part #10450195; ET560/40x, ET630/75m 
wavelengths), CFP filter (Leica Part #10447409; ET436/20x, ET480/40m wavelengths) and a triple filter for GFP/RFP/CFP  (Leica Part 
#10450611; ET434.5/21, 501.5/19, 574.5/23, ET469.5/25, 536.5/29, 635.5/69 wavelengths) using a Leica M165FC fluorescent 
stereomicroscope. (A) WT mosquitoes. (B) Cas9 marked with Opie2-CFP. (C) gRNAmyo-fem marked with 3xp3-tdTomato. (D) gRNAβTub 
marked with 3xp3-GFP. (E) gRNAβTub+myo-fem marked with 3xp3-GFP and 3xp3-tdTomato. (F) Cas9 + gRNAβTub+myo-fem marked with 
Opie2-CFP, 3xp3-GFP, and 3xp3-tdTomato. Arrows indicate points of focus where markers can easily be distinguished. Yellow box 
indicates the life stage in which the transgene can be reliably distinguished. Green box indicates the life stage in which mosquitoes 




.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 




Figure S5. Fitness of transheterozygous pgSIT mosquitoes in comparison with WT and parental lines. Survival plots of adult ♀’s 
either cohabitated with ♂’s or not (A), and adult ♂’s either cohabitated with ♀’s or not (B). Survival means ± standard errors (SE) over 
days following adult eclosion are plotted. Vertical lines and values present median survivals for each tested group. Survival curves were 
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compared to the curve for WT’s of the corresponding sex. The departure significance was assessed with the Log-rank (Mantel-Cox) and 
Gehan-Breslow-Wilcoxon texts and is indicated above median values. The flightlessness of pgSIT♀’s affected their survival and 
drastically reduced their longevity even in the laboratory setting. Notably, the longevity of pgSIT♂’s was not significantly affected. (C) 
Larva-to-pupa and pupa-to-adult developmental times were measured in 150 ♀’s and ♂’s. (D) Plots of mating capacities for adult ♂’s 
of each genotype. (E) Plots of blood feeding rates of adult ♀’s  of each genotype. (F) Plots of fertility of  adult ♀’s  of each genotype. 
Point plots in panels C, D, E, and F show mean ± standard deviation (SD). Statistical significance was estimated using a two-sided 
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Figure S6. Illumina NGS-based amplicon sequencing results representing myo-fem and βTub knockout in pgSIT mosquitoes.  A 
zoomed in genome browser snapshot depicting amplicon sequencing based insertions/deletions (indels) at each gRNA target site of: (A) 
myo-fem exon 1 in WT individuals (25♀ + 25♂) and pgSIT individuals (25♀ + 25♂). (B) βTub exon 1 in WT individuals (25♀ + 25♂) 











Figure S7. Determination of transgene copy number using Oxford Nanopore genome sequencing. The normalized mean coverage for 
all the contigs in the genome with the exception of mtDNA, which has a coverage of 6563. These are plotted (blue) by sorting the order of the contigs 
as either (A) a mean coverage to produce a smooth line or (B) by contig size. The green horizontal lines correspond to the standard deviation. (C) A 
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Figure S8. Integrated genome browser snapshot depicting pgSIT sequencing results for myo-fem. (A) A zoomed out image of the 
myo-fem gene structure with a green box highlighting exon 1 targeted by the gRNAs. (B-E) A zoomed in genome browser snapshot of 
exon 1 depicting: (B) Oxford nanopore sequencing results depicting CRISPR/Cas9-mediated mutations in the DNA sequence of myo-
fem exon 1.  (C) Illumina transcriptome RNA-sequencing results of WT sequences (3 replicates) showing the lack of mutations as 
compared to (D) depicting mutations in the coding sequence of myo-fem exon 1 in pgSIT individuals (3 replicates). (E) Depicts the 
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Figure S9. Integrated genome browser snapshot depicting pgSIT sequencing results for βTub. A genome browser snapshot of 
βTub depicting: (A) A zoomed out image of the βTub gene structure with a green box highlighting the exon targeted by gRNAs. (B-E) 
A zoomed in genome browser snapshot of exon-1 depicting: (B) Oxford nanopore sequencing results depicting disruptions in the DNA 
sequence of βTub exon 1. (C) Illumina transcriptome RNA-sequencing of WT sequences (three replicates) showing the lack of mutations 
as compared to (D) depicting mutations in the coding sequence of  βTub exon 1 in pgSIT individuals  (three replicates). (E) Depicts the 















.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.05.434167doi: bioRxiv preprint 
27 
 
Figure S10. Transcriptional profiling and expression analysis. (A) Hierarchical clustering and (B) PCA analysis of the 12 samples 
used for RNA sequencing. (C-E) MA-plots showing the differential expression patterns between: (C)  pgSIT♀  vs WT ♀, (D) pgSIT♂’s 
vs WT ♂, (E) two-factor pgSIT vs WT. Significantly differentially expressed genes are indicated by blue dots (FDR < 0.5), non-
significantly differentially expressed genes are indicated by grey dots, target genes are indicated by red dots, transgene encoded genes 
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Figure S11. Scaling pgSIT to control populations of mosquitoes and molecular mechanisms. (A) A factory produces pgSIT eggs 
for distribution and release at remote locations worldwide. The global map depicts the probability of occurrence of Ae. aegypti (from 0 
blue to 1 red) at a spatial resolution of 5 km × 5 km (adopted from (28)). (B) Punnett squares depict the F1 genotypes derived from 
bidirectional crosses between homozygous gRNAβTub+myo-fem and Cas9. To the right, is a schematic depicting the genetic outcome of a 

















.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.05.434167doi: bioRxiv preprint 
29 
Supplemental Tables 
Table S1. myo-fem and βTub developmental gene expression data. Ae. albopictus and Ae. aegypti myo-fem and  βTub TPM gene 
expression across different developmental timepoints 
Table S2. Embryo microinjection and transgenic line generation 
Table S3. Single gene disruption 
Table S4. pgSIT cross data    
Table S5. Life Parameters. Comparisons of life parameters of different mosquito lines. To evaluate the potential fitness costs associated 
with the pgSIT components, several life-table parameters such as fecundity, larval development time, ♂ insemination capacity, mating 
competitiveness, and adult survival rate were measured among WT, homozygous gRNAβTub+myo-fem, homozygous Cas9 and heterozygous 
pgSIT lines (gRNAβTub+myo-fem,+/Cas9,+). Compared to WT, homozygous gRNAβTub+myo-fem, homozygous Cas9, and pgSIT♂’s that 
produced from maternal Cas9 or paternal Cas9 had no significant differences in larval and pupal survival rate, larval and pupal 
development time, ♂ insemination ability, and adult survival (p < 0.05). Maternal Cas9 refers to paternal gRNAβTub/+; gRNAmyo-
fem/+; maternal Cas9/+, and paternal Cas9 corresponds to maternal gRNAβTub/+; gRNAmyo-fem/+; paternal Cas9/+. Each strain is 
labeled with a superscript (a-e) and is used to indicate where the significance lies. For example, an ANOVA with a post hoc Tukey’s 
analysis for ♀ fecundity indicates differences are between wildtype vs gRNA, wildtype vs Cas9, and wildtype vs transheterozygotes. 
Table S6. pgSIT flight capacity assay. Flight activities were monitored over a 24-hour period using the DAM system. The counts are 
the number of times the mosquitoes passed the infrared beam.  
Table S7. Sound attraction assay  
Table S8. pgSIT♂ sterilize WT ♀’s 
Table S9. The mean coverage depth from the Nanopore DNA sequencing for all contigs in the genome (2310) and the three plasmids 
(OA-1067A1: gRNAβTub;  OA-1067K: gRNAmyo-fem; and OA-874PA: Nup50-Cas9) as well as normalized coverage based on the global 
number (Table S12). Transgene coverage ranged from 5.1 to 7.6 and normalized coverage ranged from 0.93 to 1.38. 
Table S10. Nanopore coverage means 
Table S11. Mapping Stats for RNA sequencing 
Table S12. RNAseq expression data 
Table S13. deseq2_liverpool_males_pgSIT_males.annotations  
Table S14. deseq2_liverpool_females_pgSIT_females.annotations.xlsx  
Table S15. deseq2_liverpool_pgSIT.annotations 
Table S16. Multigenerational population cage data 
Table S17. Parameters used in Aedes aegypti population suppression model. 
Table S18. Primer and gRNA sequences 
 
Supplemental Figures 
Figure S1. Conservation of target genes in Diptera. 
Figure S2. Assessment of independent gRNAβTub lines. 
Figure S3. Assessment of independent gRNAmyo-fem lines. 
Figure S4. Transmitted light and fluorescent images of mosquito life stages of strains used in this study. 
Figure S5. Fitness of transheterozygous pgSIT mosquitoes in comparison with WT and parental lines. 
Figure S6. Illumina NGS-based amplicon sequencing results representing myo-fem and βTub knockout in pgSIT mosquitoes.  
Figure S7. Determination of transgene copy number using Oxford Nanopore genome sequencing. 
Figure S8. Integrated genome browser snapshot depicting pgSIT sequencing results for myo-fem. 
Figure S9. Integrated genome browser snapshot depicting pgSIT sequencing results for βTub. 
Figure S10. Transcriptional profiling and expression analysis. 
Figure S11. Scaling pgSIT to control populations of mosquitoes and molecular mechanisms. 
 
Supplemental Videos 
Video S1. Timelapse of βTub mutant and WT testes and sperm.  βTub mutant and WT testes were imaged at 10X and 63X.  
Video S2. myo-fem mutant ♀’s eclosing. Flightless myo-fem mutant ♀’s have abnormal wing postures restricting their escape from 
rearing cups following eclosion, which reduces survival.   
Video S3. Timelapse of myo-fem mutant flight. Cages consisting of myo-fem mutant ♀’s, myo-fem mutant ♂’s, WT ♀’s, and WT ♂’s 
were recorded over 5.5 minutes. The cages were occasionally tapped to stimulate movement.  
Video S4. Timelapse of pgSIT and WT mosquitoes. Cages consisting of pgSIT mutant ♀’s, pgSIT♂’s, WT ♀’s, and WT ♂’s were 
recorded for 5.5 minutes. The cages were occasionally tapped to stimulate movement/flight.  
Video S5. DAM assay video. Short clip of the DAM assay’s monitor tube in action with a WT ♀ passing the infrared beam during 
flight.  
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Video S6. Male courtship assay. pgSIT males are strongly attracted to the female flight tone indicating strong mating behavior.  
Video S7. Model-predicted impact of releases of pgSIT eggs in Onetahi, Tetiaroa, French Polynesia. Time-series for female Ae. 
aegypti population density and elimination probability are depicted for four sample release schemes depicted in Figure 4. 
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